Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Betaine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | APEX1 | P27695 | 1/20 | 0.44 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.33 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | GALR3 | O60755 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14311922 | 0.95 | TSHR (0.40) | TSHRLMNAALDH1A1APEX1CHRM2 | |
| Hydrochloric Acid SCHEMBL1904153 | 0.93 | TSHR (0.39) | TSHRLMNAALDH1A1APEX1CHRM2 | |
| Betaine SCHEMBL821050 | 0.81 | TSHR (0.34) | TSHRLMNAALDH1A1APEX1 | |
| SCHEMBL2022220 | 0.78 | TSHR (0.42) | TSHRALDH1A1CHRM2CHRM4CHRM1 | |
| Betaine SCHEMBL6140458 | 0.77 | TSHR (0.45) | TSHRLMNAALDH1A1APEX1CHRM2 | |
| Hydrochloric Acid SCHEMBL28053346 | 0.76 | TSHR (0.41) | TSHRLMNAALDH1A1CHRM2CHRM4 | |
| Bromide SCHEMBL28749870 | 0.76 | TSHR (0.41) | TSHRALDH1A1CHRM2CHRM4CHRM1 | |
| SCHEMBL13460300 | 0.75 | TSHR (0.40) | TSHRALDH1A1CHRM2CHRM4CHRM1 | |
| SCHEMBL12027956 | 0.75 | TSHR (0.40) | TSHRALDH1A1CHRM2CHRM4CHRM1 | |
| SCHEMBL19347551 | 0.74 | TSHR (0.42) | TSHRALDH1A1CHRM2CHRM4CHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6335005-B1 | Aqueous cosmetic compounds | BASF AKTIENGESELLSCHAFT (DE) | 2002-01-01 | — | — | US | claimed |
| US-20100273016-A1 | SURFACE TREATMENT AGENT FOR PAPER | KAO CORPORATION (JP) | 2010-10-28 | — | — | US | disclosed |
| EP-2199463-A1 | SURFACE TREATMENT AGENT FOR PAPER | Kao Corporation (JP) | 2010-06-23 | — | — | EP | disclosed |
| EP-0750905-B1 | Patch comprising water soluble adhesive sheet | KAO CORP (JP) | 2003-01-02 | — | — | EP | disclosed |
| EP-1192930-A1 | Film-forming cosmetic composition | L'OREAL (FR) | 2002-04-03 | — | — | EP | disclosed |
| US-6335005-B1 | Aqueous cosmetic compounds | BASF AKTIENGESELLSCHAFT (DE) | 2002-01-01 | — | — | US | disclosed |
| US-20010043911-A1 | Containing a disinfectant or an antiperspirant and a thickener; quick-drying (<30 seconds); long-lasting deodorizing effect; softness; dryness; materials handling | KAO CORPORATION (JP) | 2001-11-22 | — | — | US | disclosed |
| EP-1055405-A1 | COSMETIC PREPARATION | Kao Corporation (JP) | 2000-11-29 | — | — | EP | disclosed |
| US-5780047-A | USEFUL DURING BATHING, CAPABLE OF IMPROVING TOPICAL CIRCULATORY DYNAMICS AND METABOLISM, EXERTING MEDICINAL EFFECTS ON PAINFUL STIFF NECK AND SHOLDERS, SKIN DISORDERS AND LUMBAGO | KAO CORPORATION (JP) | 1998-07-14 | — | — | US | disclosed |
| EP-0750905-A2 | Patch comprising water soluble adhesive sheet | KAO CORPORATION (JP) | 1997-01-02 | — | — | EP | disclosed |
| EP-0424112-A2 | Nail make-up composition | KAO CORPORATION (JP) | 1991-04-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010043911-A1 | Containing a disinfectant or an antiperspirant and a thickener; quick-drying (<30 seconds); long-lasting deodorizing effect; softness; dryness; materials handling | CUTA, DEK, DSG1 | TSHR 2535/4885LMNA 4595/4885ALDH1A1 1075/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.